date:Dec 04, 2019
its European production and supply chain set up successfully, BASF is ready to collaborate with interested partners in greater Europe, Garbotz adds.
With over 700 million people living in Europe and its overarching regulatory framework for Food for Special Medical Purposes (FSMPs), Europe as a whole represents an attractive growth opportunity for BASF in its expansion plans for Hepacor. We are in advanced discussions with potential partners for upcoming launches in selected countries in Europe